Tianmu Pharmaceutical: The stock has consecutively deviated from the value for three days, with a cumulative increase of over 20%.

Tianmu Pharmaceutical announced that the closing price of the company's stock deviated by 20% for three consecutive trading days from January 19 to January 21, 2026, indicating abnormal fluctuations. The company conducted a self-inspection and verified with the controlling shareholder Huilong Huaze that current production and operation are normal, there is no undisclosed material information to disclose, and no significant impact media reports or market rumors affecting the stock price have been found. The company's controlling shareholder, directors, and senior management did not buy or sell company stocks during the abnormal fluctuation period. The company reminds investors to pay attention to trading risks.